Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Eric W. Miller, Benjamin Roberts, Kara Keeton, Andrew Monnot, Taylor Tarpey, Nicole Zoghby, Alan Segrave & Jennifer S. Pierce. (2022) Evaluation of asbestos exposure resulting from simulated application of spiked talcum powders. Inhalation Toxicology 34:13-14, pages 380-398.
Read now
Read now
Bertram Price. (2022) Projection of future numbers of mesothelioma cases in the US and the increasing prevalence of background cases: an update based on SEER data for 1975 through 2018. Critical Reviews in Toxicology 52:4, pages 317-324.
Read now
Read now
Dennis Paustenbach, David Brew, Sabina Ligas & Jonathan Heywood. (2021) A critical review of the 2020 EPA risk assessment for chrysotile and its many shortcomings. Critical Reviews in Toxicology 51:6, pages 509-539.
Read now
Read now
A. Michael Ierardi, Claire Mathis, Ania Urban, Neva Jacobs, Brent Finley & Shannon Gaffney. (2021) Potential airborne asbestos exposures in dentistry: a comprehensive review and risk assessment. Critical Reviews in Toxicology 51:4, pages 301-327.
Read now
Read now
Laura M Enomoto, Perry Shen, Edward A Levine & Konstantinos I Votanopoulos. (2019) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations. Cancer Management and Research 11, pages 4231-4241.
Read now
Read now
Ulaş Alabalık, Gül Türkcü, Ayşe Nur Keleş, İbrahim İbiloğlu, Zuhat Urakçı & Hüseyin Büyükbayram. (2017) Aquaporin 1, Aquaporin 3 and Aquaporin 5 expression and EGFR mutation in malignant pleural mesotheliomas: an imunohistochemical and molecular study. Biotechnology & Biotechnological Equipment 31:2, pages 367-372.
Read now
Read now
Francine Baumann & Michele Carbone. (2016) Environmental risk of mesothelioma in the United States: An emerging concern—epidemiological issues. Journal of Toxicology and Environmental Health, Part B 19:5-6, pages 231-249.
Read now
Read now
Joey Y. Zhou. (2014) Bias in the proportionate mortality ratio analysis of small study populations: A case on analyses of radiation and mesothelioma. International Journal of Radiation Biology 90:11, pages 1075-1079.
Read now
Read now
Suresh H. Moolgavkar, Elizabeth L. Anderson, Ellen T. Chang, Edmund C. Lau, Paul Turnham & David G. Hoel. (2014) A review and critique of U.S. EPA's risk assessments for asbestos. Critical Reviews in Toxicology 44:6, pages 499-522.
Read now
Read now
S Jane Henley, Theodore C Larson, Manxia Wu, Vinicius C S Antao, Mary Lewis, Germania A Pinheiro & Christie Eheman. (2013) Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. International Journal of Occupational and Environmental Health 19:1, pages 1-10.
Read now
Read now
Ellen P. Donovan, Brooke L. Donovan, Meg A. McKinley, Dallas M. Cowan & Dennis J. Paustenbach. (2012) Evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature. Critical Reviews in Toxicology 42:9, pages 703-731.
Read now
Read now
Angeline Lazarus, Ali Massoumi, Jordanna Hostler & David C. Hostler. (2012) Asbestos–Related Pleuropulmonary Diseases: Benign and Malignant. Postgraduate Medicine 124:3, pages 116-130.
Read now
Read now
B.
W. Case, J.
L. Abraham, G. Meeker, F.
D. Pooley & K.
E. Pinkerton. (2011) Applying Definitions of “Asbestos” to Environmental and “Low-Dose” Exposure Levels and Health Effects, Particularly Malignant Mesothelioma. Journal of Toxicology and Environmental Health, Part B 14:1-4, pages 3-39.
Read now
Read now
Bertram Price. (2010) Industrial-grade talc exposure and the risk of mesothelioma. Critical Reviews in Toxicology 40:6, pages 513-530.
Read now
Read now
Articles from other publishers (126)
Tatiana Bolgeo, Roberta Di Matteo, Stefania Crivellari, Denise Gatti, Antonella Cassinari, Carmela Riccio, Antonina De Angelis, Sara Delfanti, Elisabetta Ferrero, Claudia Gnani, Giuseppe Riili & Antonio Maconi. (2023) Quality of life in patients with PICC diagnosed with mesothelioma: Results of a multicenter epidemiological survey (LifePICC). The Journal of Vascular Access.
Crossref
Crossref
Ryan C Lewis, Sierra J Smith, Callan F Krevanko, Ethan D Hall, Eric W Miller, Evan M Beckett & Jennifer S Pierce. (2023) Occupational exposure to cosmetic talc and mesothelioma in barbers, hairdressers, and cosmetologists: A systematic review of the epidemiology. Toxicology and Industrial Health.
Crossref
Crossref
Louis Anthony Cox, Kenneth T. Bogen, Rory Conolly, Uschi Graham, Suresh Moolgavkar, Günter Oberdörster, Victor L. Roggli, Francesco Turci & Brooke Mossman. (2023) Mechanisms and shapes of causal exposure-response functions for asbestos in mesotheliomas and lung cancers. Environmental Research 230, pages 115607.
Crossref
Crossref
Dennis J. Paustenbach, Michael E. Stevens, Brett P. Tuttle, Ross A. Shore, Sabina Ligas & David W. Brew. (2023) Occupational exposure to asbestos in the steel industry (1972–2006). Journal of Exposure Science & Environmental Epidemiology.
Crossref
Crossref
Chad D. Strange, Edith M. Marom, Jitesh Ahuja, Girish S. Shroff, Gregory W. Gladish, Brett W. Carter & Mylene T. Truong. (2023) Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma. Advances in Anatomic Pathology 30:4, pages 280-291.
Crossref
Crossref
Junjie Huang, Sze Chai Chan, Wing Sze Pang, Shui Hang Chow, Veeleah Lok, Lin Zhang, Xu Lin, Don Eliseo Lucero-PrisnoIIIIII, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers & Martin C.S. Wong. (2023) Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study. Journal of Thoracic Oncology 18:6, pages 792-802.
Crossref
Crossref
Yang Wo, Yizhou Peng, Zhigang Wu, Pengcheng Liu, Yan Shang, Xuxia Shen & Yihua Sun. (2023) Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma. Cancer Medicine 12:11, pages 12452-12461.
Crossref
Crossref
Laila Belcaid, Birgitte Bertelsen, Karin Wadt, Ida Tuxen, Iben Spanggaard, Martin Højgaard, Jens Benn Sørensen, Jesper Ravn, Ulrik Lassen, Finn Cilius Nielsen, Kristoffer Rohrberg & Christina Westmose Yde. (2023) New pathogenic germline variants identified in mesothelioma. Lung Cancer 179, pages 107172.
Crossref
Crossref
Chad D. Strange, Jitesh Ahuja, Saadia A. Faiz, Horiana B. Grosu, William C. Harding, Keerthana Keshava, Carlos A. Jimenez, Vickie R. Shannon, Patricia M. de Groot, Mylene T. Truong & Cesar A. Moran. 2023. The Thorax. The Thorax
3
99
.
Weibo Wen, Dongyuan Xu, Yongnan Piao & Xiangdan Li. (2022) Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis. Cancer Cell International 22:1.
Crossref
Crossref
David B. Chapel, Jason L. Hornick, Julianne Barlow, Raphael Bueno & Lynette M. Sholl. (2022) Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Modern Pathology 35:10, pages 1383-1397.
Crossref
Crossref
Bradley Carlson, Carla Harmath, Kiran Turaga, Hedy L. Kindler, Samuel G. ArmatoIIIIII & Christopher Straus. (2022) The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review. Abdominal Radiology 47:5, pages 1725-1740.
Crossref
Crossref
Lea Belackova, Jos H Verbeek, Jan L Hoving, Henk F van der Molen, Diana Gagliardi, Stefania Curti, Carel TJ Hulshof, Paul TJ Scheepers & Alessandro Marinaccio. (2022) Legal banning of asbestos for preventing asbestos exposure. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Crossref
Marie Shamseddin, Joanna Obacz, Mathew J Garnett, Robert Campbell Rintoul, Hayley Elizabeth Francies & Stefan John Marciniak. (2021) Use of preclinical models for malignant pleural mesothelioma. Thorax 76:11, pages 1154-1162.
Crossref
Crossref
Lucia Fazzo, Alessandra Binazzi, Daniela Ferrante, Giada Minelli, Dario Consonni, Lisa Bauleo, Caterina Bruno, Marcella Bugani, Marco De Santis, Ivano Iavarone, Corrado Magnani, Elisa Romeo, Amerigo Zona, Mariano Alessi, Pietro Comba & Alessandro Marinaccio. (2021) Burden of Mortality from Asbestos-Related Diseases in Italy. International Journal of Environmental Research and Public Health 18:19, pages 10012.
Crossref
Crossref
Xaver Baur, Arthur L. Frank, Colin L. Soskolne, L. Christine Oliver & Corrado Magnani. (2021) Malignant mesothelioma: Ongoing controversies about its etiology in females. American Journal of Industrial Medicine 64:7, pages 543-550.
Crossref
Crossref
David B Chapel, Adrian M Dubuc, Jason L Hornick & Lynette M Sholl. (2021)
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with
MTAP
and
CDKN2A
copy number in malignant pleural mesothelioma
. Histopathology 78:7, pages 1032-1042.
Crossref
Crossref
Suzanne L. Walker, Janice D. Crist, Kimberly Shea, Sara Holland & Pamela Z. Cacchione. (2021) The Lived Experience of Persons With Malignant Pleural Mesothelioma in the United States. Cancer Nursing 44:2, pages E90-E98.
Crossref
Crossref
Jing Zeng, Shahed N. Badiyan, Yolanda I. Garces, Tony Wong, Xiaodong Zhang, Charles B. Simone2nd2nd, Joe Y. Chang, Antje C. Knopf, Shinichiro Mori, Hiromitsu Iwata, Arturs Meijers, Heng Li, Martin Bues, Wei Liu, Steven E. Schild & Ramesh Rengan. (2021) Consensus Statement on Proton Therapy in Mesothelioma. Practical Radiation Oncology 11:2, pages 119-133.
Crossref
Crossref
Lynnette Fernandez-Cuesta, Lise Mangiante, Nicolas Alcala & Matthieu Foll. (2021) Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Virchows Archiv 478:1, pages 73-80.
Crossref
Crossref
M. D. Ray. 2021. Multidisciplinary Approach to Surgical Oncology Patients. Multidisciplinary Approach to Surgical Oncology Patients
311
313
.
Andrew R. Barsky, Christopher A. Ahern, Sriram Venigalla, Vivek Verma, Emily J. Anstadt, Christopher M. Wright, Ethan B. Ludmir, Christopher G. Berlind, William D. Lindsay, Surbhi Grover, Keith A. Cengel & Charles B. SimoneIIII. (2020) Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma. Clinical Lung Cancer 21:6, pages e583-e591.
Crossref
Crossref
Lana Bijelic, Kathleen Darcy, Joshua Stodghill, Chunqiao Tian & Timothy Cannon. (2020) Predictors and Outcomes of Surgery in Peritoneal Mesothelioma: an Analysis of 2000 Patients from the National Cancer Database. Annals of Surgical Oncology 27:8, pages 2974-2982.
Crossref
Crossref
Feng Zhang & Weihong Gong. (2020) Prognostic and clinicopathological utility of programmed death-ligand 1 in malignant pleural mesothelioma: A meta-analysis. International Immunopharmacology 83, pages 106481.
Crossref
Crossref
Elizabeth N. Pavlisko, Beiyu Liu, Cindy Green, Thomas A. Sporn & Victor L. Roggli. (2020) Malignant Diffuse Mesothelioma in Women. American Journal of Surgical Pathology 44:3, pages 293-304.
Crossref
Crossref
Daffolyn Rachael Fels Elliott & Kirk D. Jones. (2020) Diagnosis of Mesothelioma. Surgical Pathology Clinics 13:1, pages 73-89.
Crossref
Crossref
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson & Nelya Melnitchouk. (2020) Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 57:3, pages 100727.
Crossref
Crossref
Takuya Tanaka, Koji Nakamatsu & Takahisa Imamura. (2020) Metastasis of malignant pleural mesothelioma to maxillary gingiva: A case report and literature review. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 32:2, pages 140-144.
Crossref
Crossref
Alberto M. Marchevsky, Andras Khoor, Ann E. Walts, Andrew G. Nicholson, Yu Zhi Zhang, Victor Roggli, John Carney, Anja C. Roden, Henry D. Tazelaar, Brandon T. Larsen, Nolwenn LeStang, Lucian R. Chirieac, Sonja Klebe, Ming-Sound Tsao, Marc De Perrot, Andrew Pierre, David M. Hwang, Yin P. Hung, Mari Mino-Kenudson, William Travis, Jennifer Sauter, Mary Beth Beasley & Françoise Galateau-Sallé. (2020) Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel. Modern Pathology 33:2, pages 281-296.
Crossref
Crossref
Enrico Oddone, Jordy Bollon, Consuelo Rubina Nava, Marcella Bugani, Dario Consonni, Alessandro Marinaccio, Corrado Magnani & Francesco Barone-Adesi. (2020) Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use. International Journal of Environmental Research and Public Health 17:2, pages 607.
Crossref
Crossref
WailA Eldukali, KhaledElmahdi Omran & Raouf Azzuz. (2020) Trends, and tumor characteristics of lung cancer and malignant pleural mesothelioma in the East of Libya. Ibnosina Journal of Medicine and Biomedical Sciences 0:0, pages 0.
Crossref
Crossref
Allison S. Letica-Kriegel, Joshua C. Leinwand, Joshua R. Sonett, Lyall A. Gorenstein, Robert N. Taub, John A. Chabot & Michael D. Kluger. (2019) 50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience. Annals of Surgical Oncology 27:1, pages 205-213.
Crossref
Crossref
Charles Mitchell, Vishwa Raj & Terrence Pugh. 2020. Cancer Rehabilitation. Cancer Rehabilitation
127
142
.
Edward Hammond & Keith Dredge. 2020. Heparanase. Heparanase
539
565
.
Richard L. Attanoos. 2020. Occupational Cancers. Occupational Cancers
363
378
.
Agnes B. Kane, Didier Jean, Sakari Knuutila & Marie-Claude Jaurand. 2020. Occupational Cancers. Occupational Cancers
343
362
.
Laura M. Enomoto, Perry Shen, Konstantinos I. Votanopoulos & Edward A. Levine. 2020. Cancer Regional Therapy. Cancer Regional Therapy
141
153
.
Nadine L. de Boer, Job P. van Kooten, Ronald A. M. Damhuis, Joachim G. J. V. Aerts, Cornelis Verhoef & Eva V. E. Madsen. (2019) Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study. Annals of Surgical Oncology 26:13, pages 4222-4228.
Crossref
Crossref
Lucian R. Chirieac, Yin P. Hung, Wai Chin Foo, Matthias D. Hofer, Paul A. VanderLaan, William G. Richards, David J. Sugarbaker & Raphael Bueno. (2019) Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma. Cancer 125:23, pages 4164-4171.
Crossref
Crossref
Malik Hamaidia, Hélène Gazon, Clotilde Hoyos, Gabriela Brunsting Hoffmann, Renaud Louis, Bernard Duysinx & Luc Willems. (2019) Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1–dependent mechanism. JCI Insight 4:18.
Crossref
Crossref
Michele Carbone, Prasad S. Adusumilli, H. Richard AlexanderJrJr, Paul Baas, Fabrizio Bardelli, Angela Bononi, Raphael Bueno, Emanuela Felley‐Bosco, Francoise Galateau‐Salle, David Jablons, Aaron S. Mansfield, Michael Minaai, Marc Perrot, Patricia Pesavento, Valerie Rusch, David T. Severson, Emanuela Taioli, Anne Tsao, Gavitt Woodard, Haining Yang, Marjorie G. Zauderer & Harvey I. Pass. (2019) Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA: A Cancer Journal for Clinicians 69:5, pages 402-429.
Crossref
Crossref
Fernando Espinoza-Mercado, Jerald D. Borgella, David Berz, Rodrigo F. Alban, Ariella Sarkissian, HSDG, Taryne A. Imai & Harmik J. Soukiasian. (2019) Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma. The Annals of Thoracic Surgery 108:3, pages 889-896.
Crossref
Crossref
Joey Y. ZhouStacey L. McComishSergei Y. Tolmachev. (2019) A Monte Carlo t Test to Evaluate Mesothelioma and Radiation in the US Transuranium and Uranium Registries. Health Physics 117:2, pages 187-192.
Crossref
Crossref
Olivia Sgarbura, Sophie Gourgou, Diego Tosi, Naoual Bakrin, Nabila Bouazza, Stéphanie Delaine, Hélène De Forges, Marc Pocard & François Quénet. (2019) MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma. Pleura and Peritoneum 4:2.
Crossref
Crossref
Hongbing Sun. (2019) North-south gradient of mesothelioma and asbestos consumption-production in the United States-Progresses since the 1st asbestos partial ban in 1973. American Journal of Industrial Medicine 62:4, pages 337-346.
Crossref
Crossref
Venkiteswaran Muralidhar, Pankaja Raghav, Prianka Das & Akhil Goel. (2019) A case from India of pleural malignant mesothelioma probably due to domestic and environmental asbestos exposure: a posthumous report. BMJ Case Reports 12:3, pages e227882.
Crossref
Crossref
Eric Borrelli, Zachary Babcock & Stephen Kogut. (2019) Costs of medical care for mesothelioma. Rare Tumors 11, pages 203636131986349.
Crossref
Crossref
Dario Mirabelli, Alessandro Marinaccio, Pietro Comba & Corrado Magnani. 2019. Mesothelioma. Mesothelioma
1
18
.
Brent D. Kerger. (2018) Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973–2013. BMC Research Notes 11:1.
Crossref
Crossref
Abeer A Bahnasy, Raghda Shehab El-Din, Nagwa Ali Sabri, Chahd.A. Abdel-Rahman & Ahmed El Bastawisy. (2018) BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival. Cancer Genetics 228-229, pages 83-92.
Crossref
Crossref
David A. Mahvi, Rong Liu, Mark W. Grinstaff, Yolonda L. Colson & Chandrajit P. Raut. (2018) Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA: A Cancer Journal for Clinicians 68:6, pages 488-505.
Crossref
Crossref
Brice Malgras, Etienne Gayat, Olivier Aoun, Réa Lo Dico, Clarisse Eveno, Karine Pautrat, Jean-Baptiste Delhorme, Guillaume Passot, Frédéric Marchal, Olivia Sgarbura, Gwenael Ferron, Diane Goéré, Thierry Andre & Marc Pocard. (2018) Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study. Annals of Surgical Oncology 25:11, pages 3271-3279.
Crossref
Crossref
Joanna Sesti, Sabina Musovic, Jessica S. Donington & Harvey I. Pass. 2018. Cancer Prevention and Screening. Cancer Prevention and Screening
257
273
.
Vivek Verma, Richard L. Sleightholm, Chad G. Rusthoven, Matthew Koshy, David J. Sher, Surbhi Grover & Charles B. SimoneIIII. (2018) Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Annals of Surgical Oncology 25:7, pages 2018-2026.
Crossref
Crossref
Claire Yue Li & H. Richard AlexanderJr.Jr.. (2018) Peritoneal Metastases from Malignant Mesothelioma. Surgical Oncology Clinics of North America 27:3, pages 539-549.
Crossref
Crossref
Richard L. Attanoos, Andrew Churg, Francoise Galateau-Salle, Allen R. Gibbs & Victor L. Roggli. (2018) Malignant Mesothelioma and Its Non-Asbestos Causes. Archives of Pathology & Laboratory Medicine 142:6, pages 753-760.
Crossref
Crossref
Omar Abdel-Rahman. (2018) Global trends in mortality from malignant mesothelioma: Analysis of WHO mortality database (1994-2013). The Clinical Respiratory Journal 12:6, pages 2090-2100.
Crossref
Crossref
Brandon H. Tieu, Mehee Choi, Kyle Robinson & Charles R. ThomasJrJr. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice
22
31
.
Meghan E. Glynn, Kara A. Keeton, Shannon H. Gaffney & Jennifer Sahmel. (2017) Ambient Asbestos Fiber Concentrations and Long‐Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973–2012). Risk Analysis 38:3, pages 454-471.
Crossref
Crossref
Waqas Amin, Faina Linkov, Douglas P. Landsittel, Jonathan C. Silverstein, Wiam Bshara, Carmelo Gaudioso, Michael D. Feldman, Harvey I. Pass, Jonathan Melamed, Joseph S. Friedberg & Michael J. Becich. (2019) Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Research 7, pages 1184.
Crossref
Crossref
Waqas Amin, Faina Linkov, Douglas P. Landsittel, Jonathan C. Silverstein & Michael J. Becich. (2018) Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Research 7, pages 1184.
Crossref
Crossref
Waqas Amin, Faina Linkov, Douglas P. Landsittel, Jonathan C. Silverstein & Michael J. Becich. (2018) Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Research 7, pages 1184.
Crossref
Crossref
Elizabeth Poli, Ashvin Rangole & Kiran K. Turaga. 2018. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond
361
368
.
Mary B. Rice & Jonathan M. Samet. (2017) Environmental Health: Lessons from the Past and Looking to the Future. Annals of the American Thoracic Society 14:9, pages 1378-1382.
Crossref
Crossref
Mei Zhan, Hanrui Zheng, Ting Xu, Yu Yang & Qiu Li. (2017) Cost-effectiveness analysis of additional bevacizumab to pemetrexed plus cisplatin for malignant pleural mesothelioma based on the MAPS trial. Lung Cancer 110, pages 1-6.
Crossref
Crossref
Anna K. Nowak, John G. Edwards & Jenette Creaney. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
266
284
.
Sian Cregan, Maeve Breslin, Gerard Roche, Sigrid Wennstedt, Lauren MacDonagh, Cinaria Albadri, Yun Gao, Kenneth J. O'byrne, Sinead Cuffe, Stephen P. Finn & Steven G. Gray. (2017) Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma. International Journal of Oncology 50:3, pages 1044-1052.
Crossref
Crossref
Daniel R. Gomez, Anne S. Tsao, Haining Yang & Harvey I. Pass. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
16
.
Ahmed El Bastawisy, Maha Yahia, Mohammed Rahouma, Omnia Aboelazm & Jaylan Ahmed. (2017) Malignant Pleural Mesothelioma in Young People. Journal of Cancer Therapy 08:05, pages 443-451.
Crossref
Crossref
Kohei Nakamura, Kentaro Nakayama, Risa Nagaoka, Kiyoka Nishisako, Masako Ishikawa, Hiroshi Katagiri, Tomoka Ishibashi, Emi Sato, Chika Amano & Satoru Kyo. (2017) The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases. Oncology Letters 13:1, pages 263-266.
Crossref
Crossref
Noushin Nabavi, Kevin L. Bennewith, Andrew Churg, Yuzhuo Wang, Colin C. Collins & Luciano Mutti. (2017) Switching off malignant mesothelioma: exploiting the hypoxic microenvironment. Genes & Cancer 7:11-12, pages 340-354.
Crossref
Crossref
Akiko Harada, Junji Uchino, Taishi Harada, Noriaki Nakagaki, Junko Hisasue, Masaki Fujita & Koichi Takayama. (2017) Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma. Cancer Science 108:1, pages 116-123.
Crossref
Crossref
Charles Jeff Siegert, Piero Marco Fisichella, Jennifer M. Moseley, Melina Shoni & Abraham Lebenthal. (2017) Open access phone triage for veterans with suspected malignant pleural mesothelioma. Journal of Surgical Research 207, pages 108-114.
Crossref
Crossref
Suresh H. Moolgavkar, Ellen T. Chang, Gabor Mezei & Fionna S. Mowat. 2017. Asbestos and Mesothelioma. Asbestos and Mesothelioma
43
72
.
Matthew M. Harkenrider, Scott R. Silva & Roy H. Decker. 2020. Controversies in Radiation Oncology. Controversies in Radiation Oncology
45
80
.
Carolina Mensi, Sara De Matteis, Barbara Dallari, Luciano Riboldi, Pier Alberto Bertazzi & Dario Consonni. (2016) Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections. Occupational and Environmental Medicine 73:9, pages 607-613.
Crossref
Crossref
Chi-Fu Jeffrey Yang, Brandon W. Yan, Robert Ryan Meyerhoff, Shakir M. Saud, Brian C. Gulack, Paul J. Speicher, Matthew G. Hartwig, Thomas A. D'Amico, David H. Harpole & Mark F. Berry. (2016) Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma. Clinical Lung Cancer 17:5, pages 419-426.
Crossref
Crossref
L. Greillier. (2016) Le mésothéliome : maladie orpheline ?Mesothelioma: an orphan disease?. Oncologie 18:6, pages 397-400.
Crossref
Crossref
Monica Benvenuto, Rosanna Mattera, Gloria Taffera, Maria Giganti, Paolo Lido, Laura Masuelli, Andrea Modesti & Roberto Bei. (2016) The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium. Nutrients 8:5, pages 275.
Crossref
Crossref
Sean Judge, Peter Thomas, Venkatesh Govindarajan, Poonam Sharma & Brian Loggie. (2015) Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment. Annals of Surgical Oncology 23:5, pages 1496-1500.
Crossref
Crossref
C. M. Barber, R. E. Wiggans, C. Young & D. Fishwick. (2016) UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occupational Medicine 66:2, pages 106-111.
Crossref
Crossref
C. Pérez-Guzmán, R. Barrera-Rodríguez & J. Portilla-Segura. (2016) Malignant pleural mesothelioma in a 17-year old boy: A case report and literature review. Respiratory Medicine Case Reports 17, pages 57-60.
Crossref
Crossref
B. Rau, E. Pachmayr, W. Raue & S. Weiss. 2016. Onkologische Chirurgie bei alten Patienten. Onkologische Chirurgie bei alten Patienten
223
238
.
Emanuela Taioli, Andrea S. Wolf, Marlene Camacho-Rivera, Andrew Kaufman, Dong-Seok Lee, Daniel Nicastri, Kenneth Rosenzweig & Raja M. Flores. (2015) Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients. PLOS ONE 10:12, pages e0145039.
Crossref
Crossref
Alfreda Krupoves, Michel Camus & Louise De Guire. (2015) Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032. American Journal of Industrial Medicine 58:5, pages 473-482.
Crossref
Crossref
Ottavio Rena, Renzo Boldorini, Esther Papalia, Rosanna Mezzapelle, Guido Baietto, Alberto Roncon & Caterina Casadio. (2015) Persistent Lung Expansion After Pleural Talc Poudrage in Non-Surgically Resected Malignant Pleural Mesothelioma. The Annals of Thoracic Surgery 99:4, pages 1177-1183.
Crossref
Crossref
Brandon S. Sheffield, Anna V. Tinker, Yaoqing Shen, Harry Hwang, Hector H. Li-Chang, Erin Pleasance, Carolyn Ch’ng, Amy Lum, Julie Lorette, Yarrow J. McConnell, Sophie Sun, Steven J. M. Jones, Allen M. Gown, David G. Huntsman, David F. Schaeffer, Andrew Churg, Stephen Yip, Janessa Laskin & Marco A. Marra. (2015) Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing. PLOS ONE 10:3, pages e0119689.
Crossref
Crossref
Yeon-Hee ParkJae-Woo ChoiSang-Ok JungMin-Ji ChoDa-Hyun KangChae-Uk ChungDong-Il ParkJae-Young MoonHee-Sun ParkSung-Soo JungJu-Ock KimSun-Young KimJeong-Eun Lee. (2015) Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy. Tuberculosis and Respiratory Diseases 78:3, pages 297.
Crossref
Crossref
Emanuela Taioli, Andrea S. Wolf, Jacqueline M. Moline, Marlene Camacho-Rivera & Raja M. Flores. (2015) Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma. Disease Markers 2015, pages 1-5.
Crossref
Crossref
María Dolores Martínez Miranda, Bent Nielsen & Jens Perch Nielsen. (2015) Inference and Forecasting in the Age–Period–Cohort Model with Unknown Exposure with an Application to Mesothelioma Mortality. Journal of the Royal Statistical Society Series A: Statistics in Society 178:1, pages 29-55.
Crossref
Crossref
June Freeland. 2015. Nanoengineering. Nanoengineering
637
672
.
John T. Miura, Fabian M. Johnston, T. Clark Gamblin & Kiran K. Turaga. (2014) Current Trends in the Management of Malignant Peritoneal Mesothelioma. Annals of Surgical Oncology 21:12, pages 3947-3953.
Crossref
Crossref
Paolo Girardi, Vittoria Bressan & Enzo Merler. (2014) Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region. Cancer Epidemiology 38:5, pages 496-503.
Crossref
Crossref
Emanuela Taioli, Andrea S. Wolf, Marlene Camacho-Rivera & Raja M. Flores. (2014) Women With Malignant Pleural Mesothelioma Have a Threefold Better Survival Rate Than Men. The Annals of Thoracic Surgery 98:3, pages 1020-1024.
Crossref
Crossref
Manola Comar, Nunzia Zanotta, Alessandra Bonotti, Mauro Tognon, Corrado Negro, Alfonso Cristaudo & Massimo Bovenzi. (2014) Increased Levels of C-C Chemokine RANTES in Asbestos Exposed Workers and in Malignant Mesothelioma Patients from an Hyperendemic Area. PLoS ONE 9:8, pages e104848.
Crossref
Crossref
G L Ceresoli, F Grosso, P A Zucali, M Mencoboni, G Pasello, C Ripa, D Degiovanni, M Simonelli, A Bruzzone, C Dipietrantonj, E Piccolini, G D Beretta, A G Favaretto, L Giordano, A Santoro & M Botta. (2014) Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey. British Journal of Cancer 111:2, pages 220-226.
Crossref
Crossref
Shreya J. ShettyLokesh Bathla, Venkatesh GovindarajanPeter ThomasBrian W. Loggie. (2014) Comparison of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Mitomycin or Carboplatin for Diffuse Malignant Peritoneal Mesothelioma. The American Surgeon 80:4, pages 348-352.
Crossref
Crossref
Ahmed El Bastawisy, Maha Yahia, Abdel Rahman M. Abdel Rahman & Rabab Gaafar. (2014) Prognostic Value of Neutrophil Lymphocyte Ratio in Second Line Advanced Malignant Pleural Mesothelioma. Journal of Cancer Therapy 05:07, pages 717-722.
Crossref
Crossref
Silvie Prazakova, Paul S. Thomas, Alessandra Sandrini & Deborah H. Yates. (2014) Asbestos and the lung in the 21st century: an update. The Clinical Respiratory Journal 8:1, pages 1-10.
Crossref
Crossref
Elizabeth N. Pavlisko & Thomas A. Sporn. 2014. Pathology of Asbestos-Associated Diseases. Pathology of Asbestos-Associated Diseases
81
140
.
Agnes B. Kane, Didier Jean, Sakari Knuutila & Marie-Claude Jaurand. 2014. Occupational Cancers. Occupational Cancers
299
319
.
Lucian R. ChirieacJustine A. BarlettaBeow Y. YeapWilliam G. RichardsTamara TillemanRaphael BuenoElizabeth H. BaldiniJohn GodleskiDavid J. Sugarbaker. (2013) Clinicopathologic Characteristics of Malignant Mesotheliomas Arising in Patients With a History of Radiation for Hodgkin and Non-Hodgkin Lymphoma. Journal of Clinical Oncology 31:36, pages 4544-4549.
Crossref
Crossref
Joshua C. Leinwand, Binsheng Zhao, Xiaotao Guo, Saravanan Krishnamoorthy, Jing Qi, Joseph H. Graziano, Vesna N. Slavkovic, Gleneara E. Bates, Sharyn N. Lewin, John D. Allendorf, John A. Chabot, Lawrence H. Schwartz & Robert N. Taub. (2013) Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy. Annals of Surgical Oncology 20:S3, pages 553-559.
Crossref
Crossref
Cora R. Roelofs, Gabriela J. Kernan, Letitia K. Davis, Richard W. Clapp & Phillip R. Hunt. (2013) Mesothelioma and employment in massachusetts: Analysis of cancer registry data 1988-2003. American Journal of Industrial Medicine 56:9, pages 985-992.
Crossref
Crossref
Mariette Baud, Salvatore Strano, Agnes Dechartres, Rami Jouni, Frederic Triponez, Christos Chouaid, Patricia Forgez, Diane Damotte, Nicolas Roche, Jean-François Régnard & Marco Alifano. (2013) Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. The Journal of Thoracic and Cardiovascular Surgery 145:5, pages 1305-1311.
Crossref
Crossref
Herman GibbKeri FulcherSumitha NagarajanStacey McCordNaz Afarin FallahianHeather J. HoffmanCary HaverSergei Tolmachev. (2013) Analyses of Radiation and Mesothelioma in the US Transuranium and Uranium Registries. American Journal of Public Health 103:4, pages 710-716.
Crossref
Crossref
Brent L. Finley, Jennifer S. Pierce, Dennis J. Paustenbach & David A. Galbraith. (2013) Response to a letter to the Editor by Dr. Murray M. Finkelstein regarding the article by Finley et al. (2012). Regulatory Toxicology and Pharmacology 65:1, pages 180-181.
Crossref
Crossref
Emin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, Sercan Aksoy, Umut Demirci, Mesut Seker, Hakan Harputluoglu, Nuriye Yildirim Ozdemir, Feridun Isik, Arife Ulas, Mevlude Inanc, Ulku Yalcintas Arslan, Gamze Gokoz Dogu, Abdurrahman Isikdogan & Suleyman Buyukberber. (2012) Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients. Medical Oncology 29:5, pages 3147-3154.
Crossref
Crossref
Eun‐Kee Park, Ken Takahashi, Ying Jiang, Mehrnoosh Movahed & Takashi Kameda. (2012)
Elimination of asbestos use and asbestos‐related diseases:
A
n unfinished story
. Cancer Science 103:10, pages 1751-1755.
Crossref
Crossref
Brent L. Finley, Jennifer S. Pierce, Dennis J. Paustenbach, Laura L.F. Scott, Laura Lievense, Paul K. Scott & David A. Galbraith. (2012) Malignant pleural mesothelioma in US automotive mechanics: Reported vs expected number of cases from 1975 to 2007. Regulatory Toxicology and Pharmacology 64:1, pages 104-116.
Crossref
Crossref
Victor H. Gerbaudo. 2012. A Case-Based Approach to PET/CT in Oncology. A Case-Based Approach to PET/CT in Oncology
128
173
.
Federica Grosso & Giorgio Vittorio Scagliotti. (2012) Systemic treatment of malignant pleural mesothelioma. Future Oncology 8:3, pages 293-305.
Crossref
Crossref
Sheree E. Chen & Makala B. Pace. (2012) Malignant pleural mesothelioma. American Journal of Health-System Pharmacy 69:5, pages 377-385.
Crossref
Crossref
Paul M. Claiborne, Clara S. Fowler & Ara A. Vaporciyan. (2012) Follow-up of Patients with Resected Thoracic Malignancies. Thoracic Surgery Clinics 22:1, pages 123-131.
Crossref
Crossref
Tarek Meniawy & Bruce W.S. Robinson. 2012. Clinical Respiratory Medicine. Clinical Respiratory Medicine
837
845
.
Michele Carbone, Bevan H. Ly, Ronald F. Dodson, Ian Pagano, Paul T. Morris, Umran A. Dogan, Adi F. Gazdar, Harvey I. Pass & Haining Yang. (2012) Malignant mesothelioma: Facts, Myths, and Hypotheses. Journal of Cellular Physiology 227:1, pages 44-58.
Crossref
Crossref
Linda L. Garland, Kari Chansky, Antoinette J. Wozniak, Anne S. Tsao, Shirish M. Gadgeel, Claire F. Verschraegen, Marco A. DaSilva, Mary Redman & David R. Gandara. (2011) Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509. Journal of Thoracic Oncology 6:11, pages 1938-1945.
Crossref
Crossref
Victor H. Gerbaudo, Sharyn I. Katz, Anna K. Nowak & Roslyn J. Francis. (2011) Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging. PET Clinics 6:3, pages 275-297.
Crossref
Crossref
Dario Baratti, Shigeki Kusamura & Marcello Deraco. (2011) Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research. Journal of Surgical Oncology 103:8, pages 822-831.
Crossref
Crossref
Alexander Chi, Zhongxing Liao, Nam P. Nguyen, Carol Howe, Daniel Gomez, Si Young Jang & Ritsuko Komaki. (2011) Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology 6:6, pages 1132-1141.
Crossref
Crossref
Keli M. Turner, Sheelu Varghese & H. Richard AlexanderJr.Jr.. (2011) Surgery for Peritoneal Mesothelioma. Current Treatment Options in Oncology 12:2.
Crossref
Crossref
Janakiraman Subramanian, Luis Corrales, Denis Soulieres, Daniel Morgensztern & Ramaswamy Govindan. (2011) Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) Focus on Tumor Biology and Biomarkers Related to Lung Cancer. Journal of Thoracic Oncology 6:2, pages 399-403.
Crossref
Crossref
S. W. Dean, Michael J. McCoy, Matthew E. Wolter & Kim E. Anderson. (2011) Mesothelioma in Drywall Finishing Workers. Journal of ASTM International 8:1, pages 102786.
Crossref
Crossref
Christopher King, Danira Mayes & David A. Dorsey. (2011) Benign Asbestos-Related Pleural Disease. Disease-a-Month 57:1, pages 27-39.
Crossref
Crossref
Michael T. Milano & Hong Zhang. (2010) Malignant Pleural Mesothelioma: A Population-Based Study of Survival. Journal of Thoracic Oncology 5:11, pages 1841-1848.
Crossref
Crossref
Kishor Bhatia, Rama Modali & James J. Goedert. (2010) Merkel cell polyomavirus is not detected in mesotheliomas. Journal of Clinical Virology 47:2, pages 196-198.
Crossref
Crossref